nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—Nephrotic syndrome—Dapsone—leprosy	0.0507	0.0507	CcSEcCtD
Pamidronate—Rales—Thalidomide—leprosy	0.0306	0.0306	CcSEcCtD
Pamidronate—Electrolyte imbalance—Thalidomide—leprosy	0.03	0.03	CcSEcCtD
Pamidronate—Lymphopenia—Thalidomide—leprosy	0.0245	0.0245	CcSEcCtD
Pamidronate—Serum creatinine increased—Thalidomide—leprosy	0.0204	0.0204	CcSEcCtD
Pamidronate—Hypomagnesaemia—Thalidomide—leprosy	0.0197	0.0197	CcSEcCtD
Pamidronate—Hypothyroidism—Thalidomide—leprosy	0.0195	0.0195	CcSEcCtD
Pamidronate—Hypercalcaemia—Thalidomide—leprosy	0.0181	0.0181	CcSEcCtD
Pamidronate—Interstitial lung disease—Thalidomide—leprosy	0.0177	0.0177	CcSEcCtD
Pamidronate—Psychotic disorder—Dapsone—leprosy	0.0174	0.0174	CcSEcCtD
Pamidronate—Pleural effusion—Thalidomide—leprosy	0.0164	0.0164	CcSEcCtD
Pamidronate—Nasopharyngitis—Dapsone—leprosy	0.0159	0.0159	CcSEcCtD
Pamidronate—Influenza—Dapsone—leprosy	0.0154	0.0154	CcSEcCtD
Pamidronate—Arthropathy—Thalidomide—leprosy	0.0138	0.0138	CcSEcCtD
Pamidronate—Hypocalcaemia—Thalidomide—leprosy	0.0137	0.0137	CcSEcCtD
Pamidronate—Herpes simplex—Thalidomide—leprosy	0.0136	0.0136	CcSEcCtD
Pamidronate—Bone pain—Thalidomide—leprosy	0.0131	0.0131	CcSEcCtD
Pamidronate—Sinusitis—Dapsone—leprosy	0.0129	0.0129	CcSEcCtD
Pamidronate—Hyperkalaemia—Thalidomide—leprosy	0.0123	0.0123	CcSEcCtD
Pamidronate—Candida infection—Thalidomide—leprosy	0.012	0.012	CcSEcCtD
Pamidronate—Blood urea increased—Thalidomide—leprosy	0.0118	0.0118	CcSEcCtD
Pamidronate—Pulmonary oedema—Thalidomide—leprosy	0.0112	0.0112	CcSEcCtD
Pamidronate—Erythema—Dapsone—leprosy	0.0107	0.0107	CcSEcCtD
Pamidronate—Thrombophlebitis—Thalidomide—leprosy	0.0105	0.0105	CcSEcCtD
Pamidronate—Cardiac failure congestive—Thalidomide—leprosy	0.01	0.01	CcSEcCtD
Pamidronate—Injury—Thalidomide—leprosy	0.00991	0.00991	CcSEcCtD
Pamidronate—Renal failure acute—Thalidomide—leprosy	0.00986	0.00986	CcSEcCtD
Pamidronate—Atrial fibrillation—Thalidomide—leprosy	0.00961	0.00961	CcSEcCtD
Pamidronate—Cough—Dapsone—leprosy	0.00935	0.00935	CcSEcCtD
Pamidronate—Cardiac failure—Thalidomide—leprosy	0.00933	0.00933	CcSEcCtD
Pamidronate—Lethargy—Thalidomide—leprosy	0.00929	0.00929	CcSEcCtD
Pamidronate—Osteoarthritis—Thalidomide—leprosy	0.00911	0.00911	CcSEcCtD
Pamidronate—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00911	0.00911	CcSEcCtD
Pamidronate—Psychotic disorder—Thalidomide—leprosy	0.00889	0.00889	CcSEcCtD
Pamidronate—Tachycardia—Dapsone—leprosy	0.00853	0.00853	CcSEcCtD
Pamidronate—Blood creatinine increased—Thalidomide—leprosy	0.00853	0.00853	CcSEcCtD
Pamidronate—Liver function test abnormal—Thalidomide—leprosy	0.00841	0.00841	CcSEcCtD
Pamidronate—Hypokalaemia—Thalidomide—leprosy	0.00829	0.00829	CcSEcCtD
Pamidronate—Cramp muscle—Thalidomide—leprosy	0.0082	0.0082	CcSEcCtD
Pamidronate—Insomnia—Dapsone—leprosy	0.00791	0.00791	CcSEcCtD
Pamidronate—Influenza—Thalidomide—leprosy	0.00787	0.00787	CcSEcCtD
Pamidronate—Bronchospasm—Thalidomide—leprosy	0.00774	0.00774	CcSEcCtD
Pamidronate—Neutropenia—Thalidomide—leprosy	0.00736	0.00736	CcSEcCtD
Pamidronate—Upper respiratory tract infection—Thalidomide—leprosy	0.00732	0.00732	CcSEcCtD
Pamidronate—Gastrointestinal pain—Dapsone—leprosy	0.00715	0.00715	CcSEcCtD
Pamidronate—Pneumonia—Thalidomide—leprosy	0.00706	0.00706	CcSEcCtD
Pamidronate—Infestation NOS—Thalidomide—leprosy	0.00702	0.00702	CcSEcCtD
Pamidronate—Infestation—Thalidomide—leprosy	0.00702	0.00702	CcSEcCtD
Pamidronate—Abdominal pain—Dapsone—leprosy	0.00691	0.00691	CcSEcCtD
Pamidronate—Body temperature increased—Dapsone—leprosy	0.00691	0.00691	CcSEcCtD
Pamidronate—Renal failure—Thalidomide—leprosy	0.0069	0.0069	CcSEcCtD
Pamidronate—Stomatitis—Thalidomide—leprosy	0.00684	0.00684	CcSEcCtD
Pamidronate—Conjunctivitis—Thalidomide—leprosy	0.00682	0.00682	CcSEcCtD
Pamidronate—Haematuria—Thalidomide—leprosy	0.00669	0.00669	CcSEcCtD
Pamidronate—Sinusitis—Thalidomide—leprosy	0.00658	0.00658	CcSEcCtD
Pamidronate—Agranulocytosis—Thalidomide—leprosy	0.00655	0.00655	CcSEcCtD
Pamidronate—Rhinitis—Thalidomide—leprosy	0.00632	0.00632	CcSEcCtD
Pamidronate—Urinary tract disorder—Thalidomide—leprosy	0.00622	0.00622	CcSEcCtD
Pamidronate—Urethral disorder—Thalidomide—leprosy	0.00618	0.00618	CcSEcCtD
Pamidronate—Eye disorder—Thalidomide—leprosy	0.00589	0.00589	CcSEcCtD
Pamidronate—Cardiac disorder—Thalidomide—leprosy	0.00585	0.00585	CcSEcCtD
Pamidronate—Angiopathy—Thalidomide—leprosy	0.00572	0.00572	CcSEcCtD
Pamidronate—Immune system disorder—Thalidomide—leprosy	0.00569	0.00569	CcSEcCtD
Pamidronate—Mediastinal disorder—Thalidomide—leprosy	0.00568	0.00568	CcSEcCtD
Pamidronate—Chills—Thalidomide—leprosy	0.00565	0.00565	CcSEcCtD
Pamidronate—Alopecia—Thalidomide—leprosy	0.00557	0.00557	CcSEcCtD
Pamidronate—Vomiting—Dapsone—leprosy	0.00556	0.00556	CcSEcCtD
Pamidronate—Malnutrition—Thalidomide—leprosy	0.00548	0.00548	CcSEcCtD
Pamidronate—Headache—Dapsone—leprosy	0.00548	0.00548	CcSEcCtD
Pamidronate—Tension—Thalidomide—leprosy	0.00538	0.00538	CcSEcCtD
Pamidronate—Dysgeusia—Thalidomide—leprosy	0.00537	0.00537	CcSEcCtD
Pamidronate—Nervousness—Thalidomide—leprosy	0.00533	0.00533	CcSEcCtD
Pamidronate—Back pain—Thalidomide—leprosy	0.0053	0.0053	CcSEcCtD
Pamidronate—Muscle spasms—Thalidomide—leprosy	0.00527	0.00527	CcSEcCtD
Pamidronate—Nausea—Dapsone—leprosy	0.00519	0.00519	CcSEcCtD
Pamidronate—Ill-defined disorder—Thalidomide—leprosy	0.00509	0.00509	CcSEcCtD
Pamidronate—Anaemia—Thalidomide—leprosy	0.00507	0.00507	CcSEcCtD
Pamidronate—Agitation—Thalidomide—leprosy	0.00504	0.00504	CcSEcCtD
Pamidronate—Angioedema—Thalidomide—leprosy	0.00501	0.00501	CcSEcCtD
Pamidronate—Malaise—Thalidomide—leprosy	0.00495	0.00495	CcSEcCtD
Pamidronate—Syncope—Thalidomide—leprosy	0.00492	0.00492	CcSEcCtD
Pamidronate—Leukopenia—Thalidomide—leprosy	0.00491	0.00491	CcSEcCtD
Pamidronate—Loss of consciousness—Thalidomide—leprosy	0.00482	0.00482	CcSEcCtD
Pamidronate—Cough—Thalidomide—leprosy	0.00479	0.00479	CcSEcCtD
Pamidronate—Convulsion—Thalidomide—leprosy	0.00475	0.00475	CcSEcCtD
Pamidronate—Hypertension—Thalidomide—leprosy	0.00473	0.00473	CcSEcCtD
Pamidronate—Arthralgia—Thalidomide—leprosy	0.00467	0.00467	CcSEcCtD
Pamidronate—Myalgia—Thalidomide—leprosy	0.00467	0.00467	CcSEcCtD
Pamidronate—Anxiety—Thalidomide—leprosy	0.00465	0.00465	CcSEcCtD
Pamidronate—Discomfort—Thalidomide—leprosy	0.00461	0.00461	CcSEcCtD
Pamidronate—Confusional state—Thalidomide—leprosy	0.00451	0.00451	CcSEcCtD
Pamidronate—Oedema—Thalidomide—leprosy	0.00448	0.00448	CcSEcCtD
Pamidronate—Infection—Thalidomide—leprosy	0.00445	0.00445	CcSEcCtD
Pamidronate—Shock—Thalidomide—leprosy	0.0044	0.0044	CcSEcCtD
Pamidronate—Nervous system disorder—Thalidomide—leprosy	0.00439	0.00439	CcSEcCtD
Pamidronate—Thrombocytopenia—Thalidomide—leprosy	0.00438	0.00438	CcSEcCtD
Pamidronate—Tachycardia—Thalidomide—leprosy	0.00437	0.00437	CcSEcCtD
Pamidronate—Hyperhidrosis—Thalidomide—leprosy	0.00433	0.00433	CcSEcCtD
Pamidronate—Anorexia—Thalidomide—leprosy	0.00427	0.00427	CcSEcCtD
Pamidronate—Hypotension—Thalidomide—leprosy	0.00418	0.00418	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Thalidomide—leprosy	0.00408	0.00408	CcSEcCtD
Pamidronate—Insomnia—Thalidomide—leprosy	0.00405	0.00405	CcSEcCtD
Pamidronate—Paraesthesia—Thalidomide—leprosy	0.00402	0.00402	CcSEcCtD
Pamidronate—Dyspnoea—Thalidomide—leprosy	0.00399	0.00399	CcSEcCtD
Pamidronate—Somnolence—Thalidomide—leprosy	0.00398	0.00398	CcSEcCtD
Pamidronate—Dyspepsia—Thalidomide—leprosy	0.00394	0.00394	CcSEcCtD
Pamidronate—Decreased appetite—Thalidomide—leprosy	0.00389	0.00389	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Thalidomide—leprosy	0.00386	0.00386	CcSEcCtD
Pamidronate—Fatigue—Thalidomide—leprosy	0.00386	0.00386	CcSEcCtD
Pamidronate—Constipation—Thalidomide—leprosy	0.00383	0.00383	CcSEcCtD
Pamidronate—Pain—Thalidomide—leprosy	0.00383	0.00383	CcSEcCtD
Pamidronate—Feeling abnormal—Thalidomide—leprosy	0.00369	0.00369	CcSEcCtD
Pamidronate—Gastrointestinal pain—Thalidomide—leprosy	0.00366	0.00366	CcSEcCtD
Pamidronate—Abdominal pain—Thalidomide—leprosy	0.00354	0.00354	CcSEcCtD
Pamidronate—Body temperature increased—Thalidomide—leprosy	0.00354	0.00354	CcSEcCtD
Pamidronate—Hypersensitivity—Thalidomide—leprosy	0.0033	0.0033	CcSEcCtD
Pamidronate—Asthenia—Thalidomide—leprosy	0.00321	0.00321	CcSEcCtD
Pamidronate—Pruritus—Thalidomide—leprosy	0.00317	0.00317	CcSEcCtD
Pamidronate—Diarrhoea—Thalidomide—leprosy	0.00306	0.00306	CcSEcCtD
Pamidronate—Dizziness—Thalidomide—leprosy	0.00296	0.00296	CcSEcCtD
Pamidronate—Vomiting—Thalidomide—leprosy	0.00285	0.00285	CcSEcCtD
Pamidronate—Rash—Thalidomide—leprosy	0.00282	0.00282	CcSEcCtD
Pamidronate—Dermatitis—Thalidomide—leprosy	0.00282	0.00282	CcSEcCtD
Pamidronate—Headache—Thalidomide—leprosy	0.0028	0.0028	CcSEcCtD
Pamidronate—Nausea—Thalidomide—leprosy	0.00266	0.00266	CcSEcCtD
